Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Cash & Equivalents (2016 - 2025)

Prestige Consumer Healthcare has reported Cash & Equivalents over the past 16 years, most recently at $62.4 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $62.4 million for Q4 2025, up 22.6% from a year ago — trailing twelve months through Dec 2025 was $62.4 million (up 22.6% YoY), and the annual figure for FY2025 was $97.9 million, up 110.64%.
  • Cash & Equivalents for Q4 2025 was $62.4 million at Prestige Consumer Healthcare, down from $119.1 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for PBH hit a ceiling of $163.6 million in Q2 2021 and a floor of $21.0 million in Q4 2021.
  • Median Cash & Equivalents over the past 5 years was $53.1 million (2023), compared with a mean of $64.5 million.
  • Peak annual rise in Cash & Equivalents hit 310.88% in 2022, while the deepest fall reached 78.08% in 2022.
  • Prestige Consumer Healthcare's Cash & Equivalents stood at $21.0 million in 2021, then soared by 310.88% to $86.4 million in 2022, then fell by 26.34% to $63.6 million in 2023, then dropped by 20.03% to $50.9 million in 2024, then rose by 22.6% to $62.4 million in 2025.
  • The last three reported values for Cash & Equivalents were $62.4 million (Q4 2025), $119.1 million (Q3 2025), and $139.5 million (Q2 2025) per Business Quant data.